The trial indicated an increased risk of serious cardiovascular events, such as heart attacks and strokes, after 18 months of continuous treatment. ###>On a constaté un risque accru de cardiopathies graves, telles que crise cardiaque ou accidents cérébrovasculaires, après 18 mois de traitement continu.